Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI).

Autor: Knight V; Department of Pediatrics and Children's Hospital, University of Colorado School of Medicine, Aurora, CO, United States of America. Electronic address: Vijaya.Knight@childrenscolorado.org., Askar MZ; Baylor University Medical Center, Dallas, TX, United States of America., Ntrivalas E; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Nandiwada SL; Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States of America., Peterson LK; ARUP Institute for Clinical and Experimental Pathology and Department of Pathology, University of Utah Health, Salt Lake City, UT, United States of America., Tebo AE; ARUP Institute for Clinical and Experimental Pathology and Department of Pathology, University of Utah Health, Salt Lake City, UT, United States of America., Kadkhoda K; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, United States of America., Schmitz JL; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, United States of America., Naides SJ; Euroimmun US Inc., Mountain Lakes, NJ, United States of America., Snyder MR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America., Sadighi Akha AA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: sadighiakha.amir@mayo.edu.
Jazyk: angličtina
Zdroj: Journal of immunological methods [J Immunol Methods] 2021 May; Vol. 492, pp. 112994. Date of Electronic Publication: 2021 Feb 21.
DOI: 10.1016/j.jim.2021.112994
Abstrakt: The annual meeting of the Association of Medical Laboratory Immunologists (AMLI) was convened virtually over the month of August. Prior to the emergence of the COVID-19 pandemic, AMLI's scientific committee had chosen the following topics as the focus of its 2020 meeting: Histocompatibility Testing and Transplant Immunology; Secondary Immunodeficiency and Immunotherapy Monitoring; ANA Update; and Emerging Infectious Diseases and New Algorithms for Testing. Given the central role of the discipline in the evaluation of the host response to infection, it was apt to add a separate session on antibody testing for SARS-CoV-2 infections to the original program. The current report provides an overview of the subjects discussed in the course of this meeting.
(Copyright © 2021. Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: